Patient Benefits
Provide an alternative for those unable or unwilling to use CPAP as over 50% of OSA patients are non-compliant with CPAP use.
Improve patient outcomes because OSA sufferers have a 30% higher risk of heart attack or premature
death. Stroke, diabetes, car accidents and depression are other serious OSA risks.
HCP Honorarium
Receive up to $600 in honorariums for each qualified patient you refer for a clinical trial that can improve patient outcomes.
To refer patients, please copy the below link (by clicking on the copy link button) and provide it to your patients.
http://rnsights.com/imthera1/patient_register.html
(Copy Link)
The patient will be able to register to learn more about the clinical study and provide your name as the referring HCP.
If you intend to refer a patient, click here so we can add you
to the referring HCP list to inform you of any updates to this study and notify you of your honorarium.
An honorarium of $100 will be paid when a referred patient signs the consent form and $500 will be paid when the referred patient gets the implant.
The study is intended to demonstrate the safety and efficacy of Targeted Hypoglossal Neurostimulation
(THN) for those that are unable or unwilling to use CPAP. The THN Sleep Therapy™ System is designed
to reduce or eliminate sleep apnea episodes. Essentially a pacemaker for the tongue, it provides
mild electrical stimulation to the hypoglossal nerve through a surgically implanted medical device.
Key patient inclusion criteria:
- Moderate-to-severe Obstructive Sleep Apnea
- AHI between 20 and 65
- No more than 10% central apneas
- BMI less than 35
- Unwilling or unable to use CPAP
- Willing to undergo surgery
- Have PSG (Polysomnograph) results
To receive credit for the referral, please copy the link (by clicking on the link) and provide it to your patients (Copy Link) so the patient can register to learn more about the study and provide your name as the referring HCP.
Questions from HCPs
If an HCP has any questions about the referral process or the study, please click on the red box.
Referral Letter to Patients
See attached sample letter to send to patients.
Site locations
There are study sites throughout the United States. To find a specific site near you, please click on the box.
Sleep Therapy brochure
If you suffer from obstructive sleep apnea (OSA), and have not received lasting benefit
from CPAP or other treatments, you may be a candidate for a new clinical research study.
Sleep Therapy FAQ
How long will the implant last?
The THN Sleep TherapyTM system is designed to last up to 15-years before battery replacement is required.
Pre-Screening Questionnaire
The pre-screening questionnaire is the first step toward seeing if you qualify for the THN Sleep
Therapy Study. The questionnaire will help determine if you meet some of the main criteria for the study.
Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA) is a serious medical condition that occurs when soft-tissue blocks the airway during sleep, depriving the brain of oxygen and causing sufferers to awake repeatedly throughout the night.
OSA by the Numbers
Obstructive Sleep Apnea afflicts 1 in every 5 Americans. What other problems arise for OSA patients?
